Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEMVAC in Stage IV Non-Small Cell Lung Cancer
NCT05242965Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Mar 2023
- Primary completion
- Nov 2027
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of STEMVAC in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Started Mar 2023; status: recruiting.
02
Drugs
STEMVAC
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05242965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05242965.